This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2ykm
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[ | + | ==Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (DFMB) Pyrimidine Thioether derivative, a non-nucleoside RT inhibitor (NNRTI)== |
| + | <StructureSection load='2ykm' size='340' side='right' caption='[[2ykm]], [[Resolution|resolution]] 2.90Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[2ykm]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_type_1_bh10 Human immunodeficiency virus type 1 bh10]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2YKM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2YKM FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=YKN:2-[DIFLUORO-[(4-METHYL-PYRIMIDINYL)-THIO]METHYL]-BENZOXAZOLE'>YKN</scene></td></tr> | ||
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2vg7|2vg7]], [[1ajv|1ajv]], [[1har|1har]], [[1hps|1hps]], [[1t7k|1t7k]], [[1d4j|1d4j]], [[1r0a|1r0a]], [[1hpz|1hpz]], [[2vg6|2vg6]], [[1hqe|1hqe]], [[1qe1|1qe1]], [[1npa|1npa]], [[1ajx|1ajx]], [[1ebk|1ebk]], [[1tvr|1tvr]], [[1s6p|1s6p]], [[1bqm|1bqm]], [[1ikv|1ikv]], [[1w5y|1w5y]], [[1hos|1hos]], [[1s6q|1s6q]], [[1ikw|1ikw]], [[3hvt|3hvt]], [[1ec1|1ec1]], [[1ec0|1ec0]], [[2xyf|2xyf]], [[1t05|1t05]], [[1rvq|1rvq]], [[1d4i|1d4i]], [[1meu|1meu]], [[1s9g|1s9g]], [[2be2|2be2]], [[1hnv|1hnv]], [[1rvr|1rvr]], [[1ikx|1ikx]], [[1w5w|1w5w]], [[1qmc|1qmc]], [[1iky|1iky]], [[1n6q|1n6q]], [[1d4h|1d4h]], [[1rvn|1rvn]], [[1hbv|1hbv]], [[1htf|1htf]], [[1rtd|1rtd]], [[1ec2|1ec2]], [[2hmi|2hmi]], [[1w5v|1w5v]], [[2uy0|2uy0]], [[1sv5|1sv5]], [[1hmv|1hmv]], [[2bbb|2bbb]], [[1s9e|1s9e]], [[2x4u|2x4u]], [[1n5y|1n5y]], [[1dlo|1dlo]], [[1heg|1heg]], [[1rvp|1rvp]], [[1rvl|1rvl]], [[1eet|1eet]], [[1dw6|1dw6]], [[2b6a|2b6a]], [[1w5x|1w5x]], [[1yt9|1yt9]], [[1htg|1htg]], [[1hvu|1hvu]], [[1ebw|1ebw]], [[1rdh|1rdh]], [[2ban|2ban]], [[2xye|2xye]], [[1eby|1eby]], [[1j5o|1j5o]], [[1rvo|1rvo]], [[1hvp|1hvp]], [[1mes|1mes]], [[1ec3|1ec3]], [[1hih|1hih]], [[1hef|1hef]], [[1hni|1hni]], [[1tv6|1tv6]], [[1a9m|1a9m]], [[1ebz|1ebz]], [[2b5j|2b5j]], [[1met|1met]], [[1hys|1hys]], [[1t03|1t03]], [[1axa|1axa]], [[1mer|1mer]], [[1npw|1npw]], [[3tlh|3tlh]], [[1suq|1suq]], [[2uxz|2uxz]], [[1bqn|1bqn]], [[1sbg|1sbg]], [[1hvk|1hvk]], [[1uwb|1uwb]], [[1rvm|1rvm]], [[2vg5|2vg5]], [[1hte|1hte]], [[1hrh|1hrh]], [[1npv|1npv]], [[1hqu|1hqu]]</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2ykm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2ykm OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2ykm RCSB], [http://www.ebi.ac.uk/pdbsum/2ykm PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | This paper reports the synthesis and antiviral properties of new difluoromethylbenzoxazole (DFMB) pyrimidine thioether derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. By use of a combination of structural biology study and traditional medicinal chemistry, several members of this novel class were synthesized using a single electron transfer chain process (radical nucleophilic substitution, S(RN)1) and were found to be potent against wild-type HIV-1 reverse transcriptase, with low cytotoxicity but with moderate activity against drug-resistant strains. The most promising compound 24 showed a significant EC(50) value close to 6.4 nM against HIV-1 IIIB, a moderate EC(50) value close to 54 muM against an NNRTI resistant double mutant (K103N + Y181C), but an excellent selectivity index >15477 (CC(50) > 100 muM). | ||
| - | + | Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.,Boyer J, Arnoult E, Medebielle M, Guillemont J, Unge J, Jochmans D J Med Chem. 2011 Dec 8;54(23):7974-85. Epub 2011 Nov 4. PMID:22017513<ref>PMID:22017513</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | == References == | |
| - | + | <references/> | |
| - | + | __TOC__ | |
| - | + | </StructureSection> | |
| - | + | ||
| - | == | + | |
| - | < | + | |
[[Category: Human immunodeficiency virus type 1 bh10]] | [[Category: Human immunodeficiency virus type 1 bh10]] | ||
[[Category: Arnoult, E.]] | [[Category: Arnoult, E.]] | ||
Revision as of 12:04, 29 October 2014
Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (DFMB) Pyrimidine Thioether derivative, a non-nucleoside RT inhibitor (NNRTI)
| |||||||||||
